Peplinski et al. (2021) showed that angiopoietin-2 was associated with heart failure or death among adults without cardiovascular disease at baseline and with disease severity in individuals with existing heart failure within the Multi-Ethnic Study of Atherosclerosis [34]. Here, ANGPT2 is linked to heart failure.